Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma & Leonard C Gray. (2021) Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review. Therapeutics and Clinical Risk Management 17, pages 927-949.
Read now
Read now
Dana Mohammad, Parco Chan, Janelle Bradley, Krista Lanctôt & Nathan Herrmann. (2017) Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1009-1019.
Read now
Read now
Articles from other publishers (13)
D. P. Devanand & R. Fremont. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
42
.
Ana CVV Giacomini, Barbara W Bueno, Leticia Marcon, Naiara Scolari, Rafael Genario, Konstantin A Demin, Tatyana O Kolesnikova, Allan V Kalueff & Murilo S de Abreu. (2020) An acetylcholinesterase inhibitor, donepezil, increases anxiety and cortisol levels in adult zebrafish. Journal of Psychopharmacology 34:12, pages 1449-1456.
Crossref
Crossref
Fei-Yi Zhao, Qiang-Qiang Fu, Zhen Zheng, Li-Xing Lao, Hua-Ling Song & Zumin Shi. (2020) Verum- versus Sham-Acupuncture on Alzheimer’s Disease (AD) in Animal Models: A Preclinical Systematic Review and Meta-Analysis. BioMed Research International 2020, pages 1-21.
Crossref
Crossref
Surabhi Pandey & B.K. Singh. (2020) De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer’s Agents. Current Computer-Aided Drug Design 16:1, pages 54-72.
Crossref
Crossref
Qianfeng Hu, Beibei Yu, Qinlei Chen, Yi Wang, Yun Ling, Songxian Sun, Yinlong Shi & Chunxiang Zhou. (2017) Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease. Molecular Medicine Reports.
Crossref
Crossref
Chad M. VanDenBerg & Michael W. Jann. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
329
349
.
Florindo Stella, Márcia Radanovic, Paulo Renato Canineu, Vanessa J. R. de Paula & Orestes V. Forlenza. (2015) Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Therapeutic Advances in Drug Safety 6:4, pages 151-165.
Crossref
Crossref
Megan J. Ehret & Kevin W. Chamberlin. (2015) Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?. Clinical Therapeutics 37:8, pages 1604-1616.
Crossref
Crossref
D. P. Devanand. 2015. Psychiatry. Psychiatry
2236
2260
.
Rui Zhang, Qian-Wei Miao, Chun-Xiao Zhu, Yue Zhao, Li Liu, Jun Yang & Li An. (2014) Sulforaphane Ameliorates Neurobehavioral Deficits and Protects the Brain From Amyloid β Deposits and Peroxidation in Mice With Alzheimer-Like Lesions. American Journal of Alzheimer's Disease & Other Dementiasr 30:2, pages 183-191.
Crossref
Crossref
Kyoung Ja Kwon, Min Kyeong Kim, Eun Joo Lee, Jung Nam Kim, Bo-Ryoung Choi, Soo Young Kim, Kyu Suk Cho, Jung-Soo Han, Hahn Young Kim, Chan Young Shin & Seol-Heui Han. (2014) Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. Journal of the Neurological Sciences 347:1-2, pages 66-77.
Crossref
Crossref
Caroline G.Y. Lau & Yusuke Marikawa. (2014) Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. Molecular Reproduction and Development 81:11, pages 994-1008.
Crossref
Crossref
Ivana Molino, Luisa Colucci, Angiola M. Fasanaro, Enea Traini & Francesco Amenta. (2013) Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials. The Scientific World Journal 2013, pages 1-8.
Crossref
Crossref